Company Will Produce & Market Phoenix Tears Cannabis Products at Dispensaries Throughout California
DENVER, CO - (NewMediaWire) - July 12, 2018 - Phoenix Tears today announced it has signed an agreement with Cultivation Technologies, Inc. to produce and distribute the company’s cannabis products in California. The products are expected to become available to consumers during the month of August 2018. Products will be produced through CTI’s state-licensed subsidiaries Coachella Manufacturing (www.CoachellaManufacturing.com) and distributed primarily through Coachella Distributors (www.CoachellaDistributors.com).
Since its founding in 2010, Phoenix Tears has been at the forefront of cannabis research. Through its Foundation (www.PhoenixTearsFoundation.com), Phoenix Tears has supported more than 200,000 individuals seeking help in addressing various debilitating conditions, and its official Phoenix Tears Oil has become a mainstay in the cannabis community. While there are many companies marketing themselves as providers of Phoenix Tears products, this partnership will ensure that individuals can purchase authentic Phoenix Tears products that adhere to strict protocols.
“Phoenix Tears is one of the most reputable formulators of trusted cannabis products, so we are naturally delighted that the company has selected Cultivation Technologies and its subsidiaries for its manufacturing and distribution efforts,” said Justin S. Beck of Cultivation Technologies. “California has one of the most sophisticated markets in the world, and we are extremely confident that both retailers and consumers will appreciate the unsurpassed quality of official Phoenix Tears products.”
Headquartered in Irvine, California, Cultivation Technologies maintains cannabis manufacturing and distribution facilities in Southern California’s City of Coachella, and maintains a highly successful sales and marketing organization that serves retailers across California. CTI will bring to market a number of Phoenix Tears’ cannabis products, including Phoenix Tears oils, vape cartridges and kits, as well as topical products.
According to Janet Rosendahl-Sweeney, chief executive officer and founder of Phoenix Tears, Cultivation Technologies’ infrastructure and expertise was instrumental in creating this partnership.
“The manufacturing facilities, sales force, and market knowledge certainly distinguish Cultivation Technologies in a highly-competitive, fast-moving business environment,” she explained. “Cultivation Technologies is a solid partner with the requisite resources and experience to help us quickly entrench our presence throughout California.”
To learn more about Phoenix Tears, visit www.PhoenixTearsFoundation.com
ABOUT CULTIVATION TECHNOLOGIES
Cultivation Technologies, Inc. provides infrastructure, manufacturing, extraction, distribution, technology, and branding to the legal medical cannabis industry. The company owns 6-acres in Coachella, California, which is entitled for a 111,500+ square foot facility featuring cultivation centers, manufacturing facilities, a testing lab, a distribution hub featuring transportation, and a centralized processing center. For more information, visit www.CultivationTech.com, www.CoachellaManufacturing.com, or www.CoachellaDistributors.com. The Company acquired temporary licenses for "Type 7" manufacturing and distribution from the State of California in January 2018 which operate from temporary facilities from the 6-acre Coachella site. State-licensed retailers in California are encouraged to contact Coachella Distributors to place pre-orders for Phoenix Tears products.
About Phoenix Tears
Phoenix Tears has two legally separate manufacturing companies that produce Cannabis products for consumer use. Phoenix Tears Network is focused in the Hemp Derived CBD market and produces products for distribution through traditional retail channels and the internet. Phoenix Tears LLC/Phoenix Tears Pharms LLC is focused in the medical marijuana market and produces products for distribution through Licensed Dispensaries in States that have adopted Medical Marijuana Laws. Phoenix Tears and its companies is considered one of the industry’s foremost leaders in the research, production, and use of Cannabis solutions.
Phoenix Tears is headquartered in Denver, Colorado, and has offices in Las Vegas and New York.
This press release constitutes forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, CTI capitalizing the Coachella project, technical advances in the industry, as well as political and economic conditions present within the industry. Neither CTI nor Phoenix Tears takes any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made. This press release and the information contained herein is not an offer to buy or sell securities and does not contain investment advice.
Contact: Suzanne Mattaboni Parallel Communications, Inc. email@example.com 610-261-4560